Kosuke Mukai

505 total citations
35 papers, 341 citations indexed

About

Kosuke Mukai is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Kosuke Mukai has authored 35 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Kosuke Mukai's work include Pituitary Gland Disorders and Treatments (15 papers), Adrenal Hormones and Disorders (12 papers) and Hormonal Regulation and Hypertension (11 papers). Kosuke Mukai is often cited by papers focused on Pituitary Gland Disorders and Treatments (15 papers), Adrenal Hormones and Disorders (12 papers) and Hormonal Regulation and Hypertension (11 papers). Kosuke Mukai collaborates with scholars based in Japan, Russia and United States. Kosuke Mukai's co-authors include Michio Otsuki, Iichiro Shimomura, Tetsuhiro Kitamura, Daisuke Tamada, Satoshi Ohara, Takehisa Fukui, Radenka Marić, Xue Zhang, Hiroyuki Yoshida and Reiko Hayashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Physical Review B.

In The Last Decade

Kosuke Mukai

30 papers receiving 338 citations

Peers

Kosuke Mukai
S. Ohta Japan
Kosuke Mukai
Citations per year, relative to Kosuke Mukai Kosuke Mukai (= 1×) peers S. Ohta

Countries citing papers authored by Kosuke Mukai

Since Specialization
Citations

This map shows the geographic impact of Kosuke Mukai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Mukai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Mukai more than expected).

Fields of papers citing papers by Kosuke Mukai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Mukai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Mukai. The network helps show where Kosuke Mukai may publish in the future.

Co-authorship network of co-authors of Kosuke Mukai

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Mukai. A scholar is included among the top collaborators of Kosuke Mukai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Mukai. Kosuke Mukai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watabe, Tadashi, Kosuke Mukai, Sadahiro Naka, et al.. (2025). First-in-Human Study of [211At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial). Journal of Nuclear Medicine. 66(12). jnumed.125.270810–jnumed.125.270810. 1 indexed citations
2.
Nakano, Eriko, Kosuke Mukai, Atsunori Fukuhara, et al.. (2024). Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation. Endocrine Journal. 71(5). 489–497.
3.
Obata, Yoshinari, et al.. (2024). Atypical Imaging Findings in a Cortisol-producing Adrenal Adenoma Predominantly Composed of Lipid-poor Compact Cells. JCEM Case Reports. 2(11). luae189–luae189. 1 indexed citations
5.
Okuno, Yosuke, Kosuke Mukai, Y. TAMURA, et al.. (2024). Frequent Seronegative Primary Hypothyroidism in Myxedema Coma in Japan: Three Case Reports With a Systematic Review. SHILAP Revista de lepidopterología. 2024(1). 2524019–2524019. 1 indexed citations
6.
Mukai, Kosuke, Michio Otsuki, Satoru Oshino, et al.. (2024). Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly. Pituitary. 27(5). 527–536. 1 indexed citations
7.
Obata, Yoshinari, Satoshi Kawata, Kosuke Mukai, et al.. (2024). Immune checkpoint inhibitor-related type 1 diabetes mellitus which develops long after treatment discontinuation: a case report and review of literature. Diabetology International. 15(3). 605–610.
8.
Iwata, Takamitsu, Satoru Oshino, Youichi Saitoh, et al.. (2024). Appearance of fluid content in Rathke’s cleft cyst is associated with clinical features and postoperative recurrence rates. Pituitary. 27(3). 287–293. 1 indexed citations
9.
Okuno, Yosuke, Kosuke Mukai, Shingo Fujita, et al.. (2021). Coincidence of Large Adrenal Cyst and Prominent Hyporeninemic Hyperaldosteronism. SHILAP Revista de lepidopterología. 2021(1). 8860498–8860498. 2 indexed citations
10.
Oshino, Satoru, Youichi Saitoh, Manabu Kinoshita, et al.. (2021). Characteristics of Nonfunctioning Pituitary Adenomas That Cause Secondary Adrenal Insufficiency. World Neurosurgery. 153. e275–e281. 4 indexed citations
11.
Funaki, Soichiro, Naoko Ose, Kenji Kimura, et al.. (2021). Debulking surgery for functional pleural dissemination of parathyroid carcinoma-case report. Journal of Cardiothoracic Surgery. 16(1). 86–86. 4 indexed citations
12.
Otsuki, Michio, Daisuke Tamada, Tetsuhiro Kitamura, et al.. (2021). Increased Dosage of MRA Improves BP and Urinary Albumin Excretion in Primary Aldosteronism With Suppressed Plasma Renin. Journal of the Endocrine Society. 6(1). bvab174–bvab174. 11 indexed citations
13.
Okuno, Yosuke, Satoshi Kawata, Yuri Shimizu, et al.. (2020). Oral Contraceptive Disturbed the Recovery of the Adrenal Function after Adrenalectomy in Cushing Syndrome. Internal Medicine. 60(6). 901–903.
14.
Tamada, Daisuke, Reiko Hayashi, Kosuke Mukai, et al.. (2019). The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism. Hypertension Research. 42(8). 1186–1191. 4 indexed citations
15.
Murata, Masahiko, Tetsuhiro Kitamura, Daisuke Tamada, et al.. (2017). Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. Journal of Hypertension. 35(5). 1079–1085. 41 indexed citations
16.
Kitamura, Tetsuhiro, Atsunori Fukuhara, Kosuke Mukai, et al.. (2016). Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing’s disease and subclinical Cushing’s disease. Endocrine Journal. 63(6). 545–554. 5 indexed citations
17.
Kitamura, Tetsuhiro, Michio Otsuki, Daisuke Tamada, et al.. (2014). Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome. Clinical Biochemistry. 47(18). 279–282. 4 indexed citations
18.
Matsuoka, T., M. Sakata, Yuki Nakamoto, et al.. (2014). Pressure-induced reentrant metallic phase in lithium. Physical Review B. 89(14). 48 indexed citations
19.
Kitamura, Tetsuhiro, Michio Otsuki, Daisuke Tamada, et al.. (2013). Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome. Clinica Chimica Acta. 424. 164–167. 15 indexed citations
20.
Tsuji, Akira, et al.. (1987). [A case of Cushing's syndrome caused by an adrenal black adenoma].. PubMed. 33(5). 738–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026